(Q36690341)

15 August 2017

1 reference

title

Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management (English)

1 reference

eradication of infectious diseases

15 August 2017

main subject

1 reference

Francis Delpeyroux

4

0 references

Mark A. Pallansch

8

object named as

Mark Pallansch

1 reference

15 August 2017

9

Olen Kew

1 reference

15 August 2017

Walter Dowdle

1

1 reference

15 August 2017

Harrie van der Avoort

2

1 reference

15 August 2017

Esther de Gourville

3

1 reference

15 August 2017

Jagadish Desphande

5

1 reference

15 August 2017

Tapani Hovi

6

1 reference

15 August 2017

Javier Martin

7

1 reference

15 August 2017

Chris Wolff

10

1 reference

15 August 2017

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

26

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

1449-1469

1 reference

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Size and structure of ECHO, poliomyelitis, and measles viruses determined by ionizing radiation and ultrafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Salmonella typhi: the laboratory as a reservoir of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

The changing pattern of poliomyelitis observed in two urban epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Differences between the thermal inactivation of picornaviruses at "high" and "low" temperatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Polio eradication: the OPV paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

The biologic principles of poliovirus eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Quantifying water pathogen risk in an epidemiological framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Virus survival as a seasonal factor in influenza and polimyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Viremia in human poliomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Transgenic mice susceptible to poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Two epidemiologic patterns of norovirus outbreaks: surveillance in England and wales, 1992-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Development of a more thermostable poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Foodborne and waterborne infectious diseases. Contributing factors and solutions to new and reemerging pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Poliovirus surveillance by examining sewage water specimens: studies on detection probability using simulation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Poliovirus spreads from muscle to the central nervous system by neural pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Present status of attenuated live-virus poliomyelitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Aerosol production associated with clinical laboratory procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Seasonal distribution of adenoviruses, enteroviruses and reoviruses in urban river water

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00844.X

10.1111/J.1539-6924.2006.00844.X

21 January 2018

Identifiers

DOI

1 reference

release_6go445lrbnabdltphchoynii7q

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6go445lrbnabdltphchoynii7q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference